PRESS RELEASE published on 06/08/2026 at 15:13, 3 months 12 days ago Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT AI Software Guerbet Intrasense DUOnco™ Pancreas PMDA Certification
BRIEF published on 02/05/2026 at 15:34, 7 months 15 days ago Intrasense Revenue Rises 43% in 2025 Order Intake Intrasense Revenue Myrian® Sales AI-enhanced Imaging CE Markings
BRIEF published on 02/05/2026 at 15:31, 7 months 15 days ago Intrasense: Revenue growth of 43% by 2025 Intrasense Myrian® Revenue 2025 AI Medical Imaging Growth In Europe
PRESS RELEASE published on 02/05/2026 at 15:29, 7 months 15 days ago Annual revenue for 2025 up 43% to €3.2 million, in line with annual targets Intrasense reports 43% revenue increase to €3.2 million in 2025, meeting targets. Strong international sales for Myrian®. Innovation strategy with certifications Revenue Increase Certifications Financial Targets Intrasense Myrian
BRIEF published on 12/18/2025 at 18:03, 9 months 2 days ago Intrasense: Confirmation of 2025 Objectives and Strategic Adjustment Innovation Medical Imaging Intrasense Geographic Expansion 2025 Goals
PRESS RELEASE published on 08/13/2025 at 16:03, 1 year 1 month ago INTRASENSE : DUOnco™ Pancreas CE marking: a key innovation for the early detection of pancreactic cancer using AI Intrasense obtains CE marking under MDR for DUOnco™ Pancreas, an AI solution enhancing early detection of pancreatic cancer. CEO Alexandre Salvador highlights the innovation's importance in clinical practice and patient care AI Pancreatic Cancer CE Marking Intrasense DUOnco Pancreas
BRIEF published on 08/13/2025 at 15:59, 1 year 1 month ago Intrasense Obtains CE Certification for DUOnco™ Pancreas, a Breakthrough in Oncology Artificial Intelligence Oncology CE Certification Intrasense DUOnco™ Pancreas
BRIEF published on 07/28/2025 at 10:40, 1 year 1 month ago Half-Yearly Review of the Intrasense Liquidity Contract Liquidity Contract Actions Stock Market Transactions FASD Intrasense
BRIEF published on 06/06/2025 at 15:12, 1 year 3 months ago Intrasense Expands AI Solutions in Oncological Imaging Intrasense AI Imaging Oncology Solutions Myrian® DUOnco™
PRESS RELEASE published on 06/06/2025 at 15:07, 1 year 3 months ago Activity Update: structured offering of AI Solutions in oncological imaging and initial successful deployments Intrasense provides structured AI solutions for oncological imaging, incl. Myrian®, DUOnco™, and Liflow®. Successful deployments & collaborations enhance patient care AI Solutions Medical Imaging Collaborations Intrasense Oncological Imaging
Published on 09/19/2026 at 00:55, 2 days 6 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 2 days 9 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 2 days 11 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 17 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/21/2026 at 07:29, 15 minutes ago EQS-Adhoc: Berentzen-Gruppe AG signs business combination agreement with Sazerac and supports voluntary public takeover offer to all shareholders at a price of EUR 5.55 per share
Published on 09/21/2026 at 07:15, 30 minutes ago EQS-WpÜG: Takeover Offer / Target company: Berentzen-Gruppe Aktiengesellschaft; Bidder: Blitz 26-877 GmbH (zukünftig Sazerac Germany Holding GmbH)
Published on 09/21/2026 at 07:05, 40 minutes ago New De'Longhi Study Reveals Europe's "Signature Order" Coffee Culture Across 35 Cities
Published on 09/21/2026 at 07:00, 45 minutes ago Strongest half-year in Curatis’s history — revenue up 51% and significant progress on corticorelin (C-PTBE-01)
Published on 09/21/2026 at 07:00, 45 minutes ago Arbonia is selling its former corporate centre for approx. CHF 21 million
Published on 09/21/2026 at 07:00, 45 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 13 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 3 days 14 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany